Karen L. Smith - EVP, Chief Medical Officer at Emergent BioSolutions Inc.

Issuer-level insider activity

Role
EVP, Chief Medical Officer
Issuer ticker
EBS on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Karen L. Smith since 04 Aug 2025

Reported holdings for Karen L. Smith in Emergent BioSolutions Inc.

Form 4 holding EVP, Chief Medical Officer

Emergent BioSolutions Inc.

Security class
Common Stock
Shares / value
11,888
Estimated value
$21,636
Report date
07 May 2021
Price
$1.82
Ownership
Direct

Transaction history for Karen L. Smith in Emergent BioSolutions Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .